A Novel SRSF3 Inhibitor, SFI003, Exerts Anticancer Activity against Colorectal Cancer by Modulating the SRSF3/DHCR24/ROS Axis

Scientists proposed a functional serine/arginine-rich splicing factor 3 (SRSF3) inhibitor for colorectal cancer (CRC) therapy and elucidated its antitumor mechanisms.